SA¹ú¼Ê´«Ã½

Tuesday 22 October 2024
Salisbury Foundation Trust

FOI_6552

Internal Reference Number: FOI_6552

Date Request Received: 13/04/2022 00:00:00

Date Request Replied To: 12/05/2022 00:00:00

This response was sent via: By Email

Request Summary: Treatment of dermatological conditions

Request Category: Companies

 
Question Number 1:
How many patients were treated in last 4 months by the Dermatology department with each of the following:
• Abrocitinib
• Acitretin
• Alitretinoin
• Azathioprine
• Baricitinib
• Ciclosporin
• Dupilumab
• Methotrexate
• Mycophenolate mofetil
• Pimecrolimus
• Tacrolimus ointment
• Tralokinumab
• Upadacitinib
 
Answer To Question 1:
Abrocitinib 0
Acitretin 25
Alitretinoin 8
Azathioprine 5
Baricitinib 0
Ciclosporin 9
Dupilumab 15
Methotrexate 16
Mycophenolate <5
Pimecrolimus 15
Tacrolimus ointment 25
Tralokinumab 0
Upadacitinib 0
 
Question Number 2:
Of the patients treated in the last 4 months with any of the products listed in Q1, how many patients were paediatric (age 17 or under)?
 
Answer To Question 2:
None
 
Question Number 3:
How many patients were treated in the last 4 months with phototherapy (UVB or PUVA) for atopic Dermatitis ONLY?
 
Answer To Question 3:
From the 01/01/22- 30/4/2022 we have had 10 patients attend the department for PUVA/UVB treatment for atopic dermatitis only.
 
To return to the list of all the FOI requests please click here

Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Person Centred & Safe

Professional

Responsive

Friendly

Progressive

SA¹ú¼Ê´«Ã½, SA¹ú¼Ê´«Ã½ Hospital, Odstock Road, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2024 SA¹ú¼Ê´«Ã½
Trust Values